Condition: Posterior Vitreous Detachment · Myopic Vitreopathy · VISION DEGRADING MYODESOPSIA · Sponsor: VMR Consulting, Inc.
The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser. The FDA has approved the use of this laser to treat membranes in the eye.
This description comes directly from the study's public registry record.
Dr Jerry Sebag, MD, FACS, FRCOphth, FARVO · 714-901-7777 · JSebag@vmrinstitute.com
Always discuss trial participation with your own doctor first.
| VMR Institute for Vitreous Macula Retina | Huntington Beach, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06915922